BOBBI SANDERS: Open Payments
NPI 1396150017 · TUPELO, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$399 in 13 payments from 7 companies in 2025. Trend: 2023 $421 · 2024 $225 · 2025 $399
Food & beverage: $399
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 2 | $179 |
| Lilly USA, LLC | 4 | $70 |
| United Therapeutics Corporation | 2 | $56 |
| Dexcom, Inc. | 2 | $35 |
| Boston Scientific Corporation | 1 | $29 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
| ABBVIE INC. | 1 | $14 |
Products named: KYPHON EXPRESS II KYPHOPAK TRAY, MOUNJARO, Tyvaso, Dexcom G6 Transmitter, WATCHMAN FLX, CAPLYTA, VRAYLAR.
Industry payments across MS — which companies pay providers there.
